Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603229 Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
83 GF Score
Price ¥8.09
GF Value ¥10.22
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Zhejiang Ausun Pharmaceutical Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SHSE:603229 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Ausun Pharmaceutical Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Short Interest falls into.


SHSE:603229
83GF Score
Zhejiang Ausun Pharmaceutical Co Ltd SHSE:603229
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Ausun Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.09 is trading 20.8% below its estimated GF Value™ of ¥10.22. GuruFocus considers Zhejiang Ausun Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603229:

  • Short Interest:
  • GF Value™: ¥10.22 vs. price of ¥8.09 (20.8% below fair value)
  • GF Score™: 83/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603229 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Ausun Pharmaceutical Co Business Description

Address No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
83GF Score

Get the complete analysis for SHSE:603229

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.09
Price
¥10.22
GF Value